Efficacy of Surgical Systems in Combination With Phacoemulsification: a Retrospective Analysis
Part of paid clinical trials in Mesa, Arizona.
- Sponsor
- Barnet Dulaney Perkins Eye Centers
- Study ID
- NCT06953349
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Real-World efficacy of Hydrus Microstent with OMNI Surgical System in combination with Phacoemulsification: a retrospective analysis — PROCEDUREThe use of combination Phacoemulsification, OMNI Canaloplasty and Hydrus microstent successfully lowers IOP in ethnically-diverse patients with Open Angle Glaucoma
Study Details
Real-World efficacy of Hydrus Microstent with OMNI Surgical System in combination with Phacoemulsification: a retrospective analysis
Key Dates
- Start date
- Mar 31, 2025
- Status verified
- Mar 2025
- Primary completion
- Nov 30, 2025
- Completion
- Dec 31, 2025
Study Design
- Enrollment
- 300 participants (estimated)
Arms
- Arm: Single Group/Cohort retrospectively utilizedThis will be 300 eyes that have undergone the combination of Phacoemulsification, OMNI Canaloplasty and Hydrus microstent that will successfully lower IOP in ethnically-diverse patients with Open Angle Glaucoma
Primary Outcome Measure
Measured Efficacy of Surgical Process with Phacoemulsification [ Time Frame: 24 months ]
Central Contacts
- Derek J Arnson, Master of Education4804201005
- Christine Funke, Medical Doctor4804201005
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Barnet Dulaney Perkins Eye Center | Mesa | Arizona | 85206 | Christine Funke, Medical Doctor (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Mesa, AZ
By condition
By specialty
By research site
Related Studies
- A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both EyesPHASE1 · Recruiting · Amneal Pharmaceuticals, LLC · Bakersfield, California
- Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication UsePHASE4 · Recruiting · University of Miami · Miami, Florida
- A Study of Outcomes Following Bio-Reinforced Canaloplasty in Eyes With Open-Angle GlaucomaEnrolling By Invitation · Iantrek, Inc. · Chico, California